Currently, Medicare has to wait seven years after a traditional drug gets approved by the U.S. Food and Drug Administration ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United ...

Trump's order targets a key problem facing Americans—that they pay much more for prescription medications than consumers ...

This month, the Centers for Medicare and Medicaid Services will begin meeting with patients who use the 15 drugs it selected ...

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries ...

The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

U.S. Trump suggests his opinion of Taylor Swift has made her less popular ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

The president announced last week that his administration would be instituting a “most favored nation” policy that would peg ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...